CFDE Data Portal | Search BUD23

	Label	Description
	BUD23 Gene (Entity type)	ENSG00000071462 - BUD23 rRNA methyltransferase and ribosome maturation factor
	BUD23 HUMAN Protein (Entity type)	18S rRNA (guanine-N(7))-methyltransferase
	BUD23 YEAST Protein (Entity type)	18S rRNA (guanine(1575)-N(7))-methyltransferase
	BUD23 MOUSE Protein (Entity type)	18S rRNA (guanine-N(7))-methyltransferase
	BUD23 DICDI Protein (Entity type)	Probable 18S rRNA (guanine-N(7))-methyltransferase
	BUD23 BOVIN Protein (Entity type)	18S rRNA (guanine-N(7))-methyltransferase
	GSE252944 AKT inhibition 10 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE144443 0 V 6 NICOTINAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS

BUD23

ENSG00000071462 - BUD23 rRNA methyltransferase and ribosome maturation factor

BUD23 HUMAN

18S rRNA (guanine-N(7))-methyltransferase

BUD23 YEAST

18S rRNA (guanine(1575)-N(7))-methyltransferase

BUD23 MOUSE

18S rRNA (guanine-N(7))-methyltransferase

BUD23 DICDI

Probable 18S rRNA (guanine-N(7))-methyltransferase

BUD23 BOVIN

18S rRNA (guanine-N(7))-methyltransferase

GSE252944 AKT inhibition 10 v 15 human dn

A Gene Set from LINCS

GSE226249 pirfenidone HL 2 v 1 human up

A Gene Set from LINCS

GSE144443 0 V 6 NICOTINAMIDE MOUSE UP

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.